Arcutis Biotherapeutics annual debt-to-assets ratio
2019
2020
2021
2022
2023
2024
2025
Arcutis Biotherapeutics Debt-to-Assets Ratio Growth & History (ARQT)
Arcutis Biotherapeutics's debt-to-assets ratio was 0.26 for fiscal 2025.
View full Arcutis Biotherapeutics company overviewArcutis Biotherapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.26 | −0.05 | −16.55% |
| 2024 | 2024-12-31 | 0.32 | −0.29 | −47.45% |
| 2023 | 2023-12-31 | 0.60 | 0.15 | +33.80% |
| 2022 | 2022-12-31 | 0.45 | 0.26 | +137.25% |
| 2021 | 2021-12-31 | 0.19 | 0.17 | +1041.76% |
| 2020 | 2020-12-31 | 0.02 | 0.01 | +480.12% |
| 2019 | 2019-12-31 | 0.00 | — | — |
Arcutis Biotherapeutics quarterly debt-to-assets ratio
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.23 | −0.08 | −25.26% |
| Q1 2026 | 2026-03-31 | 0.25 | −0.07 | −22.58% |
| Q4 2025 | 2025-12-31 | 0.26 | −0.05 | −16.55% |
| Q3 2025 | 2025-09-30 | 0.31 | −0.17 | −35.57% |
| Q2 2025 | 2025-06-30 | 0.31 | −0.15 | −33.02% |
| Q1 2025 | 2025-03-31 | 0.32 | −0.11 | −25.47% |
| Q4 2024 | 2024-12-31 | 0.32 | −0.29 | −47.45% |
| Q3 2024 | 2024-09-30 | 0.48 | −0.22 | −32.00% |
| Q2 2024 | 2024-06-30 | 0.47 | −0.17 | −26.71% |
| Q1 2024 | 2024-03-31 | 0.43 | −0.10 | −19.39% |
| Q4 2023 | 2023-12-31 | 0.60 | 0.15 | +33.80% |
| Q3 2023 | 2023-09-30 | 0.70 | 0.30 | +76.64% |
| Q2 2023 | 2023-06-30 | 0.64 | 0.38 | +144.77% |
| Q1 2023 | 2023-03-31 | 0.54 | 0.32 | +150.64% |
| Q4 2022 | 2022-12-31 | 0.45 | 0.26 | +137.25% |
| Q3 2022 | 2022-09-30 | 0.40 | 0.38 | +2832.45% |
| Q2 2022 | 2022-06-30 | 0.26 | 0.25 | +2091.96% |
| Q1 2022 | 2022-03-31 | 0.21 | 0.20 | +1896.21% |
| Q4 2021 | 2021-12-31 | 0.19 | 0.17 | +1041.76% |
| Q3 2021 | 2021-09-30 | 0.01 | −0.01 | −27.81% |
| Q2 2021 | 2021-06-30 | 0.01 | −0.00 | −25.39% |
| Q1 2021 | 2021-03-31 | 0.01 | 0.01 | +932.25% |
| Q4 2020 | 2020-12-31 | 0.02 | 0.01 | +480.12% |
| Q3 2020 | 2020-09-30 | 0.02 | — | — |
| Q2 2020 | 2020-06-30 | 0.02 | — | — |
| Q1 2020 | 2020-03-31 | 0.00 | — | — |
| Q4 2019 | 2019-12-31 | 0.00 | — | — |
Arcutis Biotherapeutics debt-to-assets ratio trends
Over the last five fiscal years, Arcutis Biotherapeutics's debt-to-assets ratio increased from 0.02 to 0.26, a change of 0.25. The latest reported quarter, Q2 2026, shows 0.23.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Arcutis Biotherapeutics source filings ↗